BMS-684
BMS-684 is a selective DGKα inhibitor with an IC50 of 15 nM. BMS-684 inhibits DGKα kinase activity with >100-fold selectivity over the related DGK type I family members DGKβ and DGKγ. BMS-684 does not inhibit any of the other seven DGK isozymes[1].
Product Specifications
CAS Number
313552-29-3
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
DGK
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bms-684.html
Purity
99.76
Solubility
DMSO : 14.29 mg/mL (ultrasonic; warming)
Smiles
CN(C1=CC=CC=C1C(N2CCN(C(C3=CC=CC=C3)C4=CC=CC=C4)CC2)=C5[N+]([O-])=O)C5=O
Molecular Formula
C27H26N4O3
Molecular Weight
454.52
Precautions
H315, H319, H335
References & Citations
[1]Michael Wichroski, et al. DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunity. Sci Transl Med. 2023 Oct 25;15 (719) :eadh1892.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E2428 96 Tests
Immunoglobulin-Like and Fibronectin Type III domain-containing protein 1 (IGFN1) Mouse ELISA Kit
Sign In for Pricing
View Details 